CD8(+) T cells are very important in cancer immunotherapy because they produce IFNγ, which activates the STAT1 signalling pathway, inhibits SLC7A11 expression and induces ferroptosis in tumour cells.39 The gene discussed is CD8A; the disease is neoplasm.